Conmed (CNMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Core Viewpoint - The upcoming earnings report for Conmed is anticipated to show a year-over-year increase in earnings and revenues, with the stock's movement largely dependent on the actual results compared to expectations [13]. Earnings Expectations - Conmed is expected to report quarterly earnings of $0.92 per share, reflecting a year-over-year increase of +10.8% [2]. - Revenues are projected to be $334.56 million, which is a 5.3% increase from the same quarter last year [3]. Estimate Revisions and Predictions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating that analysts have not significantly altered their views [4]. - The Zacks Earnings ESP model suggests that the Most Accurate Estimate is the same as the Zacks Consensus Estimate, resulting in an Earnings ESP of 0% [9]. Historical Performance - In the last reported quarter, Conmed was expected to post earnings of $0.74 per share but exceeded expectations with earnings of $0.79, resulting in a surprise of +6.76% [11]. - Over the past four quarters, Conmed has beaten consensus EPS estimates three times [19]. Current Stock Rating - Conmed currently holds a Zacks Rank of 4, indicating a "Sell" rating, which complicates the prediction of an earnings beat [10][17].